Micro Injection Molding Medical Devices 2026
Micro Injection Molding of Medical Devices 2026
Micro injection molding enables parts with masses as low as 0.1 mg and feature dimensions in the tens-of-micrometers range. It underpins microfluidic diagnostics, drug delivery components, and implantable micro-components across the current medtech innovation cycle.
Precision Polymer Processing at the Micro Scale
Micro injection molding (µIM) fabricates parts and features at sub-millimeter to micrometer scales, with masses as low as 0.1 mg, feature dimensions of tens to hundreds of micrometers, and aspect ratios exceeding 3:1. The technology intersects materials science, precision tooling, process control, and medical regulatory compliance.
Core process mechanics differ fundamentally from conventional injection molding. Dramatically reduced shot volumes produce significantly altered flow and temperature profiles, with downstream consequences for semicrystalline morphology and part properties. Dedicated µIM machines have been shown to outperform conventionally modified machines in capability index metrics for TPE micro medical parts.
Simulation of µIM requires micro-scale adaptations of commercial flow tools. Factors including heat transfer coefficient, wall slip, venting, and freeze temperature must be explicitly modeled for micro features. Multi-scale modeling approaches have predicted micro-ring outer diameter within 10 µm accuracy and flash formation on 0.1 mg micro-components.
Adjacent processes—ultrasonic molding, microcellular injection molding (MuCell), and hesitation injection molding—are represented in this landscape as complementary or alternative approaches for specific device classes, including heat-sensitive polymer components and integrated microfluidic lab-on-chip devices.
Publication Activity and Process Capability Benchmarks
Within this dataset, publication density is highest in the 2018–2022 window, indicating active industrial and academic investment. Dedicated µIM machines demonstrate superior process capability indexes versus conventional machines for TPE micro medical parts.
µIM Publication Volume by Era (Records in Dataset)
The 2018–2022 era accounts for the highest concentration of publications in this dataset, reflecting the convergence of simulation, soft tooling, and organ-on-chip research.
↗ Click bars to exploreApplication Domain Distribution in Retrieved Records
Microfluidics and lab-on-chip diagnostics represent the most heavily documented application domain in this dataset, followed by organ-on-chip platforms and surgical instruments.
↗ Click bars to exploreKey Application Areas Across the µIM Medical Device Landscape
Micro injection molding serves multiple distinct medical device application domains within this dataset, ranging from microfluidic diagnostics and organ-on-chip platforms to orthopedic implants and precision drug delivery. Each domain presents specific requirements for feature resolution, material compatibility, and production scalability.
Microfluidic Lab-on-Chip Diagnostics
Injection-molded open microfluidic well plate inserts enable spontaneous capillary flow platforms inserted into standard well plates for co-culture and microscopy (2019). The MV-IMPACT platform (2022) uses injection-molded microfluidic arrays to produce 28 vascularized tissue units per standard slide for high-throughput vascular phenotypic screening. SABIC’s hesitation injection molding patent family (WO 2017, EP 2019) directly targets lab-on-chip device manufacture via single-machine multi-step sequences.
Lab-on-Chip DiagnosticsOrgan-on-Chip and MPS Platforms
Injection-molded single-use microfluidic chips are identified as the cost-efficiency backbone of commercial organ-on-chip (OoC) platforms (2019). Channel geometry, feature consistency, floor thickness, and surface polishing are documented as critical quality metrics for cell culture applications (2017). Rapid injection molding enables mainstream biological adoption by producing dimensionally consistent micro-channels compatible with standard cell assay workflows.
Microphysiological SystemsOrthopedic Implants and Surgical Instruments
Metal injection molding (MIM) of maxillofacial orthopedic implants was studied using Sigmasoft simulation to eliminate incomplete fill defects in green parts (2021). A surgical micro-stitch marker device was optimized using Autodesk Moldflow Insight simulation in an early industrial case study (2014). These records document µIM and MIM as production routes for precision surgical and implantable components requiring tight dimensional tolerances.
Implantable ComponentsDrug Delivery and Cell Therapy Devices
An automated injection device for intradermal delivery of cell-based therapy was developed with adjustable injection depth, dose volume, and needle insertion speed—all dependent on precision micro-molded components (2017). Injection-molded drug delivery components represent a key sub-domain where µIM enables the dimensional precision required for consistent intradermal dosing in preclinical and clinical settings.
Drug Delivery SystemsKey Patent Holders in Micro Injection Molding for Medical Devices
Within this dataset, SABIC Global Technologies B.V. is the sole named patent assignee, holding a PCT (WO) and EP patent family covering hesitation injection molding for microfluidic device manufacture. The broader innovation landscape is distributed across academic and institutional research organizations rather than concentrated in a small number of IP holders.
Named Patent Assignees by Filing Count (Dataset)
↗ Click bars to exploreSABIC Global Technologies B.V.
SABIC Global Technologies B.V. holds a two-member patent family covering hesitation injection molding for microfluidic lab-on-chip device manufacture, with a PCT filing (WO, 2017) and a European regional phase (EP, 2019). The patents cover multi-step injection sequences to create closing layers over microchannels and sensors on a single machine, as well as overmolding of planar barriers, microchannel integration, and sensor securing. This family represents a meaningful attempt to consolidate process IP around integrated microfluidic device production.
Netherlands — EP/WOBalai Besar Logam dan Mesin
Balai Besar Logam dan Mesin (Center for Metal and Machinery, Indonesia) contributed a 2021 study on injection process parameter analysis for metal injection molding (MIM) of green part orthopedic implants, using Sigmasoft simulation to eliminate incomplete fill defects in maxillofacial implant components. This represents the dataset’s primary institutional contribution from Southeast Asia focused on MIM process optimization for medical-grade implants.
IndonesiaNext-Generation Capabilities in µIM for Medical Devices
The most recent records in this dataset (2020–2023) signal convergence between µIM and pharmaceutical screening infrastructure, digital twin process control, and alternative molding processes that address specific medical device limitations.
High-Throughput Biology Arrays via µIM
The MV-IMPACT platform (2022) demonstrates injection-molded microfluidic arrays producing 28 vascularized tissue units per standard slide, optimized for pharmaceutical screening workflows. This signals a shift from single-device fabrication toward array formats directly integrated into drug discovery infrastructure. The convergence of µIM with high-throughput biology platforms represents a commercially significant growth vector.
Digital Twin and API-Driven Process Control
A 2020 study documents real-time acquisition of up to 97 machine and process parameters via open API architectures using ENGEL machines with EMI protocol, enabling closed-loop digital twin implementations for µIM. In situ time-resolved small-angle X-ray scattering at synchrotron beamlines (2022) provides a 4D morphology monitoring approach as an analytical foundation for next-generation process understanding and quality control.
Micro Injection Molding vs. Conventional Injection Molding: Key Dimensions
Click any row to explore further.
| Dimension | Micro Injection Molding (µIM) | Conventional Injection Molding |
|---|---|---|
| Part mass range | As low as 0.1 mg | Typically grams to kilograms |
| Feature dimensions | Tens to hundreds of micrometers; aspect ratios exceeding 3:1 | Millimeter to centimeter scale features |
| Dedicated machines | Required for optimal capability index; dedicated µIM machines outperform modified conventional machines for TPE micro medical parts | Standard injection molding machines; modified versions show lower capability indexes for micro parts |
| Simulation requirements | Requires micro-scale adaptations: heat transfer coefficient, wall slip, venting, freeze temperature must be explicitly modeled | Commercial macro simulation software (e.g. Moldflow) applicable without micro-scale adaptations |
| Tooling options | Hard steel, DLP-printed soft tooling (100–200 µm features), mortar material inserts, Al-filled epoxy rapid tooling (~1,300-cycle life) | Primarily hard steel tooling; service lives orders of magnitude above soft tooling alternatives |
| Morphology outcomes | Significantly altered flow and temperature profiles produce distinct semicrystalline morphological outcomes versus macro-scale | Standard morphology development; well-characterized by conventional simulation and DSC methods |
| Key medical applications | Microfluidic diagnostics, organ-on-chip, drug delivery, surgical micro-instruments, implantable micro-components | Medical housings, larger device enclosures, standard tubing and connectors |
Frequently Asked Questions: Micro Injection Molding for Medical Devices
Micro injection molding can fabricate parts with masses as low as 0.1 mg, feature dimensions in the range of tens to hundreds of micrometers, and aspect ratios exceeding 3:1, as documented in this dataset.
A 2020 functional analysis validation study quantitatively demonstrated superior capability indexes for dedicated µIM machines over conventional machines when producing thermoplastic elastomer (TPE) micro medical parts using multi-cavity molds. The dramatically reduced shot volume requires precision dosing units, high injection speeds, and integrated monitoring that conventional machines lack.
Hesitation injection molding is a multi-step injection sequence performed on a single machine to create closing layers over microchannels and embedded sensors in lab-on-chip devices. SABIC Global Technologies B.V. holds a PCT (WO, 2017) and European (EP, 2019) patent family covering this approach for microfluidic device manufacture.
This dataset documents DLP-based thermoset polymer inserts capable of replicating 100 µm wide micro-features in high-flow polypropylene, DLP-manufactured inserts for 200 µm diameter pillars in polyethylene, and mortar material inserts capable of replicating QR codes in ABS polymer. Al-filled epoxy rapid tooling offers approximately 1,300-cycle service life and a reported 30% cost reduction versus conventional tooling.
Heat transfer coefficient, wall slip, venting, and freeze temperature must be explicitly modeled for micro features. A 2019 simulation validation study identified heat transfer coefficient as the dominant parameter for replication fidelity in a microfluidic flow cytometer chip. Multi-scale modeling has achieved micro-ring outer diameter prediction within 10 µm accuracy.
Microfluidics and lab-on-chip diagnostics is the most heavily represented domain in this dataset, including flow cytometry chips, vascularized tissue arrays, and co-culture platforms. Other key domains include organ-on-chip and microphysiological systems, surgical micro-instruments, orthopedic and maxillofacial implants (via MIM), and precision drug delivery devices.
Data and insights on this page are based on a limited patent and literature dataset and are for reference only. Figures may not represent the complete technology landscape.